Time-restricted feeding for obese adolescents
The Effect of Time-Restricted Feeding on Body Composition and Some Metabolic Parameters in Obese Adolescents
This study tests if a specific eating schedule can help obese teenagers lose weight and improve their health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 12 Years to 18 Years |
| Sex | All |
| Sponsor | TC Erciyes University Academic / other |
| Locations | 1 site (Kayseri) |
| Trial ID | NCT06616454 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of time-restricted feeding on body composition and metabolic parameters in obese adolescents aged 12-18. The intervention involves a structured eating schedule that aligns with circadian rhythms, aiming to promote weight loss and improve metabolic health. Participants will be monitored for changes in body weight and metabolic markers over the course of the intervention. The study seeks to provide a simple and effective dietary modification that can enhance adherence to weight management strategies in this population.
Who should consider this trial
Good fit: Ideal candidates are obese adolescents aged 12-18 with a metabolic disorder and stable body weight.
Not a fit: Patients with endocrine disorders, chronic diseases, or those who are unable to adhere to the time-restricted feeding protocol may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to significant improvements in weight management and metabolic health for obese adolescents.
How similar studies have performed: While time-restricted feeding has shown positive effects in adults, there is limited data on its effectiveness in adolescents, making this approach relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adolescents aged 12-18 with puberty stage:5 * Obese adolescents with a metabolic disorder (such as fatty liver, insulin resistance, prediabetes, dyslipidemia) (BMI≥95th percentile for age) * Those who have a stable body weight for 3 months before the start of the study (current weight gain or loss \<4 kg) * Those who own and can use a Smartphone with Apple iOS or Android operating system * Those who speak, read and understand Turkish Exclusion Criteria: * Those with any endocrine disorder, metabolic, chronic or major psychiatric disease other than obesity, insulin resistance, dyslipidemia, prediabetes, fatty liver * Polycystic ovary syndrome (PCOS) * Those with physical or mental disabilities * Those with allergies, intolerances or eating disorders * Those who smoke and drink alcohol * Use of drugs that may affect study results, circadian rhythms or metabolism (such as antidiabetics, steroids, beta blockers, adrenergic stimulating agents, laxatives, etc.)
Where this trial is running
Kayseri
- Mustafa Eraslan and Fevzi Mercan Children's Hospital — Kayseri, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Sümeyra Başar
- Email: sumeyra_akalin@hotmail.com
- Phone: + 90 538 638 0089
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.